The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma

Standard

The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma. / Neidert, Marian C; Hostettler, Isabel C; Burkhardt, Jan-Karl; Mohme, Malte; Held, Ulrike; Kofmehl, Reto; Eisele, Günter; Woernle, Christoph M; Regli, Luca; Bozinov, Oliver.

In: NEUROSURG REV, Vol. 39, No. 3, 07.2016, p. 401-9.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Neidert, MC, Hostettler, IC, Burkhardt, J-K, Mohme, M, Held, U, Kofmehl, R, Eisele, G, Woernle, CM, Regli, L & Bozinov, O 2016, 'The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma', NEUROSURG REV, vol. 39, no. 3, pp. 401-9. https://doi.org/10.1007/s10143-015-0698-z

APA

Neidert, M. C., Hostettler, I. C., Burkhardt, J-K., Mohme, M., Held, U., Kofmehl, R., Eisele, G., Woernle, C. M., Regli, L., & Bozinov, O. (2016). The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma. NEUROSURG REV, 39(3), 401-9. https://doi.org/10.1007/s10143-015-0698-z

Vancouver

Bibtex

@article{8c85fb43acff4d53b86fcaaf4fc15edc,
title = "The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma",
abstract = "The purpose of the present study is to analyze the impact of intraoperative resection control modalities on overall survival (OS) and progression-free survival (PFS) following gross total resection (GTR) of glioblastoma. We analyzed data of 76 glioblastoma patients (30f, mean age 57.4 ± 11.6 years) operated at our institution between 2009 and 2012. Patients were only included if GTR was achieved as judged by early postoperative high-field MRI. Intraoperative technical resection control modalities comprised intraoperative ultrasound (ioUS, n = 48), intraoperative low-field MRI (ioMRI, n = 22), and a control group without either modality (n = 11). The primary endpoint of our study was OS, and the secondary endpoint was PFS-both analyzed in Kaplan-Meier plots and Cox proportional hazards models. Median OS in all 76 glioblastoma patients after GTR was 20.4 months (95 % confidence interval (CI) 18.5-29.0)-median OS in patients where GTR was achieved using ioUS was prolonged (21.9 months) compared to those without ioUS usage (18.8 months). A multiple Cox model adjusting for age, preop Karnofsky performance status, tumor volume, and the use of 5-aminolevulinic acid showed a beneficial effect of ioUS use, and the estimated hazard ratio was 0.63 (95 % CI 0.31-1.2, p = 0.18) in favor of ioUS, however not reaching statistical significance. A similar effect was found for PFS (hazard ratio 0.59, p = 0.072). GTR of glioblastoma performed with ioUS guidance was associated with prolonged OS and PFS. IoUS should be compared to other resection control devices in larger patient cohorts.",
keywords = "Journal Article",
author = "Neidert, {Marian C} and Hostettler, {Isabel C} and Jan-Karl Burkhardt and Malte Mohme and Ulrike Held and Reto Kofmehl and G{\"u}nter Eisele and Woernle, {Christoph M} and Luca Regli and Oliver Bozinov",
year = "2016",
month = jul,
doi = "10.1007/s10143-015-0698-z",
language = "English",
volume = "39",
pages = "401--9",
journal = "NEUROSURG REV",
issn = "0344-5607",
publisher = "Springer",
number = "3",

}

RIS

TY - JOUR

T1 - The influence of intraoperative resection control modalities on survival following gross total resection of glioblastoma

AU - Neidert, Marian C

AU - Hostettler, Isabel C

AU - Burkhardt, Jan-Karl

AU - Mohme, Malte

AU - Held, Ulrike

AU - Kofmehl, Reto

AU - Eisele, Günter

AU - Woernle, Christoph M

AU - Regli, Luca

AU - Bozinov, Oliver

PY - 2016/7

Y1 - 2016/7

N2 - The purpose of the present study is to analyze the impact of intraoperative resection control modalities on overall survival (OS) and progression-free survival (PFS) following gross total resection (GTR) of glioblastoma. We analyzed data of 76 glioblastoma patients (30f, mean age 57.4 ± 11.6 years) operated at our institution between 2009 and 2012. Patients were only included if GTR was achieved as judged by early postoperative high-field MRI. Intraoperative technical resection control modalities comprised intraoperative ultrasound (ioUS, n = 48), intraoperative low-field MRI (ioMRI, n = 22), and a control group without either modality (n = 11). The primary endpoint of our study was OS, and the secondary endpoint was PFS-both analyzed in Kaplan-Meier plots and Cox proportional hazards models. Median OS in all 76 glioblastoma patients after GTR was 20.4 months (95 % confidence interval (CI) 18.5-29.0)-median OS in patients where GTR was achieved using ioUS was prolonged (21.9 months) compared to those without ioUS usage (18.8 months). A multiple Cox model adjusting for age, preop Karnofsky performance status, tumor volume, and the use of 5-aminolevulinic acid showed a beneficial effect of ioUS use, and the estimated hazard ratio was 0.63 (95 % CI 0.31-1.2, p = 0.18) in favor of ioUS, however not reaching statistical significance. A similar effect was found for PFS (hazard ratio 0.59, p = 0.072). GTR of glioblastoma performed with ioUS guidance was associated with prolonged OS and PFS. IoUS should be compared to other resection control devices in larger patient cohorts.

AB - The purpose of the present study is to analyze the impact of intraoperative resection control modalities on overall survival (OS) and progression-free survival (PFS) following gross total resection (GTR) of glioblastoma. We analyzed data of 76 glioblastoma patients (30f, mean age 57.4 ± 11.6 years) operated at our institution between 2009 and 2012. Patients were only included if GTR was achieved as judged by early postoperative high-field MRI. Intraoperative technical resection control modalities comprised intraoperative ultrasound (ioUS, n = 48), intraoperative low-field MRI (ioMRI, n = 22), and a control group without either modality (n = 11). The primary endpoint of our study was OS, and the secondary endpoint was PFS-both analyzed in Kaplan-Meier plots and Cox proportional hazards models. Median OS in all 76 glioblastoma patients after GTR was 20.4 months (95 % confidence interval (CI) 18.5-29.0)-median OS in patients where GTR was achieved using ioUS was prolonged (21.9 months) compared to those without ioUS usage (18.8 months). A multiple Cox model adjusting for age, preop Karnofsky performance status, tumor volume, and the use of 5-aminolevulinic acid showed a beneficial effect of ioUS use, and the estimated hazard ratio was 0.63 (95 % CI 0.31-1.2, p = 0.18) in favor of ioUS, however not reaching statistical significance. A similar effect was found for PFS (hazard ratio 0.59, p = 0.072). GTR of glioblastoma performed with ioUS guidance was associated with prolonged OS and PFS. IoUS should be compared to other resection control devices in larger patient cohorts.

KW - Journal Article

U2 - 10.1007/s10143-015-0698-z

DO - 10.1007/s10143-015-0698-z

M3 - SCORING: Journal article

C2 - 26860420

VL - 39

SP - 401

EP - 409

JO - NEUROSURG REV

JF - NEUROSURG REV

SN - 0344-5607

IS - 3

ER -